Business Context and Reporting Period
This Form 8-K is a current report filed by Greatbatch, Inc. (noted as Integer Holdings Corp in metadata) on March 24, 2011. The filing discloses a presentation delivered to analysts and investors at the Company's Investor Day in New York, New York, on the same date.
Key Financial Metrics
The filing text does not provide specific historical financial values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references a presentation (Exhibit 99.1) containing projections for future revenue, research and development expenses, adjusted operating margin, and growth rates.
The document defines the following non-GAAP measures used in the presentation:
- Adjusted Amounts: GAAP amounts excluding acquisition-related charges, facility consolidation, manufacturing transfer, system integration, asset write-downs, severance charges, litigation charges/gains, non-cash interest charges related to convertible debt, and unusual items.
- Free Cash Flow: Defined as cash flow from operations less amounts expended for property, plant, and equipment, net of sales proceeds.
Material Changes
The filing does not report specific material changes to financial results compared to prior periods. The primary event reported is the dissemination of forward-looking information and non-GAAP financial measures during the Investor Day presentation.
Guidance, Outlook, and Risks
Guidance and Outlook: Management provided projections regarding future sales, expenses, profitability, product development milestones, and capital expenditures. These forward-looking statements are based on current expectations and are subject to significant risks.
Risks and Contingencies: The filing lists numerous factors that could cause actual results to differ materially from projections, including:
- Dependence on a limited number of customers and customer ordering patterns.
- Pricing pressure and product obsolescence.
- Reliance on third-party suppliers for raw materials and subcomponents.
- Challenges in integrating acquisitions and realizing synergies.
- Regulatory changes in the healthcare industry and global economic factors.
- Intellectual property challenges and product liability claims.
Investor Verification Checklist
- Review Exhibit 99.1 (the Investor Day presentation) for specific numerical projections on revenue and margins.
- Consult the Form 10-K filed on March 1, 2011, for the reconciliation of non-GAAP measures to GAAP results.
- Verify the Company's ability to execute cost reduction and plant consolidation initiatives mentioned in the risk factors.
- Monitor the status of legal actions and regulatory changes affecting the healthcare sector.